MAPT and Alzheimer disease: Tau immunohistochemistry demonstrated NFTs and threads in the deep cortical layers, hippocampal formation, amygdala, mammillary body and striatum, widespread neritic and Aβ mature, and diffuse plaques in the neocortices and hippocampus, consistent with ‘intermediate’ AD neuropathological change (A3B2C3).